Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pharm-Olam Adds Scientific Director | Contract Pharma

What are you searching for?

Sign in
Promotions & Moves

Pharm-Olam Adds Scientific Director

Abhyankar to provide strategic guidance for early phase research

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dr. Dhiraj Abhyankar has been appointed director of Scientific Development at Pharm-Olam International Ltd.

Dr. Abhyankar is a medical oncologist with more than 15 years of experience at both pharmaceutical companies and CROs. He previously held positions where he was responsible for clinical research on complex drugs, novel technology, 505B2 opportunities in oncology and  a number of other therapeutics areas including respiratory, endocrinology and CNS. He also headed the team which conducted a clinical trial on the first global biosimilar monoclonal antibody.

“Dr. Abhyankar’s education and experience is a valuable addition to the Pharm-Olam team,” said Sanjiv Suri, Pharm-Olam’s chief executive officer. “Dr. Abhyankar has over a decade of experience in the development of oncology therapies in all phases of the development process. In his new role, he will play a critical part in providing strategic guidance for our clients’ early phase research, and provide medical support as treatments move through the development process. With oncology trials now comprising 25% of our total trial portfolio, the addition of Dr. Abhyankar comes at an important time.”

Pharm-Olam operates in more than 60 countries worldwide, offering clinical trial support for Phase I-IV clinical trials.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters